Publications

May 2018

Abstract

ISPOR Annual Meeting

Flatiron-authored

May 2018

Abstract

Academy Health Annual Research Meeting

Flatiron-authored

Development and Validation of a High‐Quality Composite Real‐World Mortality Endpoint

Curtis MD, Griffith S, Tucker M, Taylor M, Capra W, Carrigan G, Holzman B, Torres AZ, You P, Arnieri B, Abernethy AP

May 2018

Manuscript

Health Services Research

Flatiron-authored

Speed of Adoption of Immune Checkpoint Inhibitors of Programmed Cell Death 1 Protein and Comparison of Patient Ages in Clinical Practice vs Pivotal Clinical Trials

O’Connor J, Fessele K, Steiner J, Seidl-Rathkopf K, Carson K, Nussbaum N, Yin E, Adelson K, Presley C, Chiang A, Ross J, Abernethy AP, Gross C

May 2018

Manuscript

JAMA Oncology

Flatiron-authored

Real-World Evidence In Support Of Precision Medicine: Clinico-Genomic Cancer Data As A Case Study

Agarwala V, Khozin S, Singal G, O'Connell C, Kuk D, Li G, Gossai A, Miller V, Abernethy AP

May 2018

Manuscript

Health Affairs

Flatiron-authored

Identification of Resistance Mechanisms to EGFR Treatment in the Real World Using a Clinicogenomic Database

Singal G, Agarwal A, Kaushik G, O'Connell C, Alpha-Cobb G, Caron T, Bourque D, Guria A, Frank S, Frampton G, Carson K, Abernethy AP, Miller V

April 2018

Abstract

American Association for Cancer Research Annual Meeting

Flatiron-authored

February 2018

Manuscript

Clinical Therapeutics

Flatiron-authored

Use of Cancer Immunotherapies in the Real-World in the Setting of Microsatellite Instability

Agarwala V, Gossai A, Singal G, O'Connell C, Li G, Kao K, Bourque D, Feuchtbaum D, Nunnally A, Frampton G, Ali S, Abernethy AP, Kramarz S, Trabucco SE

January 2018

Abstract

ASCO-SITC Clinical Immuno-Oncology Symposium

Flatiron-authored

January 2018

Abstract

ASCO-SITC Clinical Immuno-Oncology Symposium

January 2018

Abstract

ASCO-SITC Clinical Immuno-Oncology Symposium

January 2018

Abstract

ASCO Gastrointestinal Cancers Symposium

Characteristics of Real-World Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab and Pembrolizumab During the Year Following Approval

Khozin S, Abernethy AP, Nussbaum N, Zhi J, Curtis MD, Tucker M, Lee S, Light D, Gossai A, Sorg R, Torres AZ, Patel P, Blumenthal G, Pazdur R

January 2018

Manuscript

The Oncologist

Flatiron-authored

Treatment Dynamics of Bone-Targeting Agents Among Men with Bone Metastases from Prostate Cancer in the United States

Butler A, Cetin K, Hernandez RK, Reams D, Overman R, Kim J, Hirsch B, Abernethy AP, Liede A, Brookhart A

January 2018

Manuscript

Pharmacoepidemiology & Drug Safety

Flatiron-authored

December 2017

Abstract

American Society of Hematology Annual Meeting

December 2017

Abstract

American Society of Hematology Annual Meeting

December 2017

Abstract

American Society of Hematology Annual Meeting

December 2017

Abstract

American Society of Hematology Annual Meeting

December 2017

Abstract

American Society of Hematology Annual Meeting

December 2017

Abstract

American Society of Hematology Oncology

December 2017

Manuscript

Clinical Pharmacology and Therapeutics

Flatiron-authored

December 2017

Abstract

San Antonio Breast Cancer Symposium

Treatment Patterns for Young Women with HR+/HER2- Metastatic Breast Cancer in the United States in the Era of CDK 4/6 Inhibitors

Burstein H, Mayer E, DeMichele A, Harnett J, Mardekian J, McRoy L, Huang Bartlett C, Koehler M, Fahed Rimawi M

December 2017

Abstract

San Antonio Breast Cancer Symposium

November 2017

Abstract

San Antonio Breast Cancer Symposium

Flatiron-authored

October 2017

Abstract

World Conference on Lung Cancer

Utilization and Timing of Foundation Medicine (FMI) Testing in U.S. Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients

Wang L, Page D, Shewade A, Lambert P, Arnieri B, Capra W, Khorshid M, Mughal T, Gay L, Foser S

October 2017

Abstract

World Conference on Lung Cancer

October 2017

Abstract

World Conference on Lung Cancer

October 2017

Abstract

World Conference on Lung Cancer

Real-World Management of Patients with EGFR Mutation-Positive NSCLC in the US

Li Y, Appius A, Pattipaka T, Feyereislova A, Cassidy A, Ganti A

October 2017

Abstract

World Conference on Lung Cancer

October 2017

Abstract

World Conference on Lung Cancer

Immune Checkpoint Inhibitor (ICPI) Efficacy and Resistance Detected by Comprehensive Genomic Profiling (CGP) in Non-Small Cell Lung Cancer (NSCLC)

Ross J, Goldberg M, Albacker L, Gay L, Agarwala V, Elvin J, Vergillo J, Ramkissoon S, Severson E, Daniel S, Ali S, Schrock A, Frampton G, Fabrizio D, Miller V, Singal G, Abernethy AP, Stephens P

September 2017

Abstract

ESMO Annual Congress

Flatiron-authored

Analyzing Biomarkers of Cancer Immunotherapy (CIT) Response Using a Real-World Clinico-Genomic Database

Singal G, Miller P, Agarwala V, Li G, Gossai A, Albacker L, Goldberg M, He J, Frank S, Bourque D, Ivanov V, Fabrizio D, Caron T, Parker A, Guria A, Miller V, Elvin J, Ross J, Abernethy AP, Stephens P

September 2017

Abstract

ESMO Annual Congress

Flatiron-authored

September 2017

Abstract

ESMO Annual Congress

September 2017

Abstract

ESMO Annual Congress

Use of Electronic Health Record Data for Quality Reporting

Abernethy AP, Gippetti J, Parulkar R, Revol C

August 2017

Manuscript

Journal of Oncology Practice

Flatiron-authored

June 2017

Manuscript

PLoS One

Flatiron-authored

June 2017

Abstract

ASCO Annual Meeting

Flatiron-authored

Implementation of the IOM 13 Point Care Plan by OCM Practices

Fargnoli B, Jaffe N, Bauer-Levey N, Cowing K, Schneider J, Parulkar R, Lee D, Harary O, Holleran R, Zhang S, Revol C, Tran D, Shah R, Abernethy AP, Kolodziej M

June 2017

Abstract

ASCO Annual Meeting

Flatiron-authored

Electronic Calculation of Quality Measures in the EMR is Highly Dependent on Data Capture in Structured Fields: The Oncology Care Model (OCM) Quality Reporting Experience

Hamrick HJ, Revol C, Parulkar R, Lemmers O, Gippetti J, Bauer-Levey N, Lee D, Fugaro A, Kolodziej M, Green R, Abernethy AP

June 2017

Abstract

ASCO Annual Meeting

Flatiron-authored

June 2017

Abstract

ASCO Annual Meeting

Flatiron-authored

Adoption of Immunotherapy into Real World Practice: Insights from the Use of Checkpoint Inhibitors

O’Connor J, Seidl-Rathkopf K, You P, Nussbaum N, Torres AZ, Fessele K, Darius K, Adelson K, Yin E, Presley C, Chiang A, Ross J, Abernethy AP, Gross C

June 2017

Abstract

ASCO Annual Meeting

Flatiron-authored

Racial Disparities in the Use of Programmed Death-1 Checkpoint Inhibitors

O’Connor J, Seidl-Rathkopf K, You P, Nussbaum N, Torres AZ, Fessele K, Darius K, Adelson K, Yin E, Presley C, Chiang A, Ross J, Abernethy AP, Gross C

June 2017

Abstract

ASCO Annual Meeting

Flatiron-authored

Disparities in Next Generation Sequencing in a Population-Based Community Cohort of Patients with Advanced Non-Small Cell Lung Cancer

Presley C, Chiang A, Longtine J, Soulos P, Adelson K, Herbst R, Nussbaum N, Sorg R, Abernethy AP

June 2017

Abstract

ASCO Annual Meeting

Flatiron-authored

Development and Validation of a Real-World Clinico-Genomic Database

Singal G, Miller P, Agarwala V, He J, Gossai A, Frank S, Bourque D, Bowser B, Caron T, Baydur E, Seidl-Rathkopf K, Ivanov I, Parker A, Guria A, Frampton G, Jaskiw A, Feuchtbaum D, Nussbaum N, Abernethy AP, Miller V

June 2017

Abstract

ASCO Annual Meeting

Flatiron-authored

June 2017

Abstract

ASCO Annual Meeting

June 2017

Abstract

ASCO Annual Meeting

Characteristics of Advanced NSCLC Patients Receiving Molecular Diagnostic Testing in US Routine Clinical Practice

Wang L, Shewade A, Lambert P, Arnieri B, Capra W, Khroshid M, Mughal T, Gay L, Page D, Foser S

June 2017

Abstract

ASCO Annual Meeting

June 2017

Abstract

ASCO Annual Meeting

Real-World Treatment Pattern and Discontinuation of Systemic Combination Therapies in Metastatic Melanoma

Qiu Y, Li Z, Tang J, Atanasov P, Mahmood S, Grzegorzewski K, Chen L, Chen J

June 2017

Abstract

ASCO Annual Meeting

May 2017

Abstract

European Lung Cancer Conference

Real-World Rates of Chemotherapy Use Near the End of Life (EOL) in Cancer Patients

Agarwala V, Kraut J, Gippetti J, Revol C, Peterson D, Fessele K, Abernethy AP

March 2017

Abstract

NCCN Annual Conference

Flatiron-authored